Trump’s IVF Push Faces Complications
President Donald Trump has taken to calling himself “the fertilization president,” which, I suppose, is interesting. However, it’s been six months since he made a formal pledge to broaden access to in vitro fertilization (IVF), and yet, the White House still hasn’t rolled out any related policy.
Ever since he campaigned on IVF, things have gotten a bit tangled. Conservative pushback has emerged, particularly from anti-abortion groups who deem IVF as unethical. Additionally, there’s the “Make America Healthy Again” movement, which raises concerns about the pharmaceutical industry’s role in fertility treatments.
In fact, several of these groups are suggesting that Trump should shift his focus to restorative reproductive medicine, a lesser-known holistic approach. This method emphasizes pinpointing and treating root causes of infertility, often through less invasive and potentially less expensive methods than IVF.
But there’s a catch: restorative reproductive medicine isn’t officially recognized as a medical specialty in the U.S., and it hasn’t been scrutinized as thoroughly as IVF. Many fertility experts worry that promoting these holistic options as superior could deprive patients of established and effective fertility treatments.
“Restorative methods may suit some patients, but labeling them as morally superior risks undermining the individualized, evidence-based care that modern reproductive medicine strives for,” said Dr. Brian Levine from CCRM Fertility in New York.
After Trump issued an executive order promising to make IVF more accessible, Republican lawmakers responded by introducing bills in Congress to bolster access to restorative reproductive medicine while placing restrictions on insurers that don’t offer IVF. Interestingly, Arkansas recently mandated insurance coverage for restorative treatments.
Recent actions from the Department of Health and Human Services indicate a leaning towards these holistic treatment methods. Calley Means from HHS noted, in a conversation with Fox News, that there was a directive to develop some sort of “holistic fertility policy.” In line with this, a team responsible for tracking IVF success rates was laid off, part of extensive restructuring within the agency.
Moreover, HHS has posted a grant opportunity for an “infertility training center,” aiming to educate individuals about various holistic infertility treatments. However, Andrew Nixon from HHS clarified that they aren’t yet seeking applications for this center.
“HHS remains committed to supporting couples facing infertility,” Nixon mentioned, referencing Trump’s IVF executive order.
Despite all this, there seems to be uncertainty within the administration regarding the direction of federal IVF policy, even as Trump refers to himself as the “father of IVF.” While the groundwork was laid decades ago for this technology, the first successful IVF birth occurred in England in 1978.
The White House Domestic Policy Council presented Trump with recommendations in May for supporting IVF. Dr. Kaylen Silverberg, who advises the council, suggested that infertility be labeled as an essential health benefit under the Affordable Care Act, thus covering IVF for military and government employees. But reports indicate that the White House may not require health insurers to cover IVF services as previously promised.
Silverberg noted that White House officials haven’t specified which policies they’re leaning towards, making the situation even murkier. “They come to me with thoughtful inquiries, yet provide little in terms of direction,” he remarked.
The administration has claimed it is engaging with various stakeholders for their perspectives. “President Trump committed to expanding access to IVF for those wanting to start families, and the administration remains dedicated to fulfilling that promise,” said White House spokesperson Kush Desai.
Restorative reproductive medicine appears to be one of the options on the table. The International Institute for Restorative Reproductive Medicine has been communicating with federal officials about its practices, as noted by its global communications director, Dr. Tracey Parnell.
Parnell, who was surprised to see her field enter the U.S. national dialogue, said, “We anticipated it would take us longer to gain recognition and publish more findings.” Gaining formal recognition here requires national board accreditation, which is no small feat.
Organizations like the Heritage Foundation, influential among conservative circles, are advocating for restorative approaches over IVF, arguing the latter profits from manipulating human life. This stance has bolstered groups opposed to IVF, according to Levine from CCRM Fertility.
Amidst all of this, there’s concern that ultra-conservative groups may utilize the current discourse around IVF and reproductive medicine to advance their agenda by critiquing standard practices.
The “Make America Healthy Again” movement, led by Health Secretary Robert F. Kennedy Jr., also shows a preference for holistic approaches. A recent roundtable organized by the Heritage Foundation and the MAHA Institute focused on women’s fertility and has attracted federal attention.
Emma Waters, a policy analyst at the Heritage Foundation, noted that the movement’s goals resonate with those of restorative reproductive medicine, even with some differences.
Parnell emphasized these methods don’t exclude IVF but offer an alternative. Practitioners of restorative reproductive medicine claim their techniques are tailored to the patient and don’t hastily label women as infertile. They often involve careful monitoring of menstrual cycles to identify ovulation timings, alongside treating medical issues affecting fertility.
While they may recommend lifestyle changes or medications to enhance ovulation, it’s important to note that IVF doctors warn these restorative approaches can be time-consuming, something many patients can’t afford. Interestingly, some methods associated with restorative medicine are already commonly found in fertility clinics.[…]
Silverberg suggested that restorative reproductive medicine might be a misnomer for long-standing practices. “My worry is that advocates of these methods may overlook significant medical advancements in the past decades,” he added.
Monica Minjeur, representing the International Institute for Restorative Reproductive Medicine, pointed out that there is evidence supporting their methods. A study of over 400 women with infertility histories showed a decent success rate after they switched to restorative techniques, similar to IVF outcomes.
While restorative reproductive medicine has gained traction among conservative supporters, Minjeur stresses its approach is not inherently political and is driven by scientific basis. “We’re simply trying to share the benefits and align with governmental priorities wherever they coincide,” she concluded.
